
An FDA advisory committee recommended six peptide substances for possible 503A-list inclusion in July 2026. Here is what that nonbinding vote means—and what it does not mean—for patients.

Retatrutide is an investigational triple agonist—not an FDA-approved medication. Learn what Phase 2 and Phase 3 research shows, known risks, and what patients can legally access today.

A physician-led decision guide to 14 questions men should ask before TRT, including diagnosis, safety, fertility, cost, hidden fees, monitoring and provider selection.

Stem cell therapy for orthopedic conditions remains an evolving and contested area of medicine.

Learn when testosterone testing is appropriate, how repeat morning results are interpreted, and what NovaGenix lab review and evaluation involve.

Learn how nutrition, resistance exercise and hydration fit GLP-1 weight loss, and why supplement claims need product-specific evidence.

Understand why winter weight loss is complex, why a plateau does not diagnose a hormone disorder, and how to plan evidence-based care.

Build a practical fall routine for sleep, nutrition and activity, and learn when persistent symptoms deserve a hormone or other medical evaluation.

A practical guide to symptom patterns in your 40s, overlapping causes, preparing for evaluation and the next steps after testosterone testing.
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed